GLP-S

Product Overview
GLP-S is a research peptide formulation consisting of semaglutide, a synthetic 31-amino acid glucagon-like peptide-1 (GLP-1) receptor agonist. This peptide is engineered with structural modifications to resist enzymatic breakdown and enable prolonged activity. GLP-S is intended strictly for laboratory research and is not approved for human or veterinary applications.

Key Features
Peptide Component: Semaglutide (GLP-1 Analog)
Peptide Structure: Modified GLP-1 analog with increased stability and bioavailability
Molecular Formula: C187H291N45O59
Molecular Weight: 4113.64 Da
Form: White to off-white lyophilized powder

Intended Research Applications

• Investigation of GLP-1 receptor activation and downstream signaling

• Studies on glucose metabolism, insulin secretion, and appetite regulation

• Research on metabolic diseases, including obesity and type 2 diabetes

• Preclinical evaluation of pharmacokinetics and structure-activity relationships

Product Attributes

Compliance Disclaimer
For Research Use Only: This product is not intended for human or veterinary use. Supply is strictly limited to laboratory research, analytical assay development, or investigative procedures only.
Not for Human Consumption: Any clinical or diagnostic use, or use as a drug, food, or cosmetic is strictly prohibited.
Handling Precautions: Employ appropriate personal protective equipment and follow institutional safety protocols for peptide handling and disposal.

Additional Information
GLP-S (Semaglutide) should be reconstituted with 0.9% benzyl alcohol solution (Bacteriostatic Water) in accordance with your laboratory’s protocols.

No therapeutic or diagnostic claims are made for this compound. All statements relate exclusively to laboratory research findings.